
Partillion Bioscience aims to broaden access to the advanced single-cell tools needed for biomedical innovation with its award-winning nanovial platform.
Market:
Emerging technologies for treatment and diagnosis rely on the use of cells to produce antibodies and other recombinant proteins. The market for monoclonal antibody discovery alone was estimated at $6.5B in 2016 and is expected to reach $10.7B by 2025. Partillion aims to penetrate the discovery market with its nanovial platform. This lab-on-a-particle system selects desired cells based on complex functions and reveals the genetic information that encodes them. The goal is to enable more labs to develop higher-performing therapies and diagnostic tests, and do it faster and cheaper.

Technology:
Partillion Bioscience’s key technology is the nanovial, a specialized hydrogel microparticle platform that enables high-throughput sorting of single cells based on their secreted products — all using standard equipment. Because instruments that sort cells are already common in the bioresearch space, the nanovial can expand the types of single-cell analyses available in just about any lab.

Advantages:
- Sorts over 100,000 cells simultaneously
- No specialized equipment needed
- Single-cell resolution
- Live cell sorting
- Profiles cells by their function
Development Stage:
- Advanced – Prototype
Select Publications:
- New Droplet Technique Accelerates Automation of Single-Cell Exploration | Society of Laboratory Automation and Screening (SLAS)
- UCLA Samueli Student is Second in History to Win Coveted Innovation Award | UCLA Samueli Newsroom
- Suspendable Hydrogel Nanovials for Massively Parallel Single-Cell Functional Analysis and Sorting | ACS Nano
- Monodisperse drops templated by 3D-structured microparticles | Science
- Fabrication of 3D concentric amphiphilic microparticles to form uniform nanoliter reaction volumes for amplified affinity assays | Lab On A Chip
Contact:
Website: www.partillion.com
Phone: (707) 529-3034
Email: joe@partillion.com
- Active Membranes, LLC.
- Avesta76 Therapeutics
- Capacity Bio
- CDR3 Therapeutics, Inc.
- Dalton Bioanalytics
- EarlyDx
- Forcyte Biotechnologies
- Gradient Orthodontics
- ImmunoVec
- Lactation Lab
- Lookin, Inc.
- Nanoarmor, LLC.
- Partillion Bioscience Corporation
- Pelage Pharmaceuticals
- Pluto Immunotherapeutics
- Scarless Laboratories
- Sorriso Pharmaceuticals
- Symphony Biosciences
- Vault Pharma
- ViBo Health
- Westwood Bioscience